These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Moss AJ; Greenberg H; Case RB; Zareba W; Hall WJ; Brown MW; Daubert JP; McNitt S; Andrews ML; Elkin AD; Circulation; 2004 Dec; 110(25):3760-5. PubMed ID: 15583079 [TBL] [Abstract][Full Text] [Related]
28. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Healey JS; Hallstrom AP; Kuck KH; Nair G; Schron EP; Roberts RS; Morillo CA; Connolly SJ Eur Heart J; 2007 Jul; 28(14):1746-9. PubMed ID: 17283003 [TBL] [Abstract][Full Text] [Related]
29. Age dependent efficacy of implantable cardioverter-defibrillator treatment: observations in 450 patients over an 11 year period. Trappe HJ; Pfitzner P; Achtelik M; Fieguth HG Heart; 1997 Oct; 78(4):364-70. PubMed ID: 9404252 [TBL] [Abstract][Full Text] [Related]
30. Outpatient inotropic therapy in heart transplant candidates: should its use influence waiting list priority status? Winkel E; Kao W; Fisher SG; Heroux AL; Johnson MR; Costanzo MR J Heart Lung Transplant; 1998 Aug; 17(8):809-16. PubMed ID: 9730431 [TBL] [Abstract][Full Text] [Related]
31. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A; Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817 [TBL] [Abstract][Full Text] [Related]
32. Improved survival of cardiac transplantation candidates with implantable cardioverter defibrillator therapy: role of beta-blocker or amiodarone treatment. Ermis C; Zadeii G; Zhu AX; Fabian W; Collins J; Lurie KG; Sakaguchi S; Benditt DG J Cardiovasc Electrophysiol; 2003 Jun; 14(6):578-83. PubMed ID: 12875416 [TBL] [Abstract][Full Text] [Related]
33. The impact of implantable cardioverter-defibrillators on mortality among patients on the waiting list for heart transplantation. Grimm M; Wieselthaler G; Avanessian R; Grimm G; Schmidinger H; Schreiner W; Podczeck A; Wolner E; Laufer G J Thorac Cardiovasc Surg; 1995 Aug; 110(2):532-9. PubMed ID: 7637372 [TBL] [Abstract][Full Text] [Related]
34. The implantable cardioverter defibrillator as a "bridge to transplant": a viable clinical strategy? Schmidinger H Am J Cardiol; 1999 Mar; 83(5B):151D-157D. PubMed ID: 10089858 [TBL] [Abstract][Full Text] [Related]
35. Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation. Sandner SE; Wieselthaler G; Zuckermann A; Taghavi S; Schmidinger H; Pacher R; Ploner M; Laufer G; Wolner E; Grimm M Circulation; 2001 Sep; 104(12 Suppl 1):I171-6. PubMed ID: 11568051 [TBL] [Abstract][Full Text] [Related]